Cannabinoids for Nerve Pain: What the Best Clinical Evidence Says About Sleep and Pain Relief

This review of cannabinoids for neuropathic pain sleep examines a 2022 meta-analysis of eight randomized controlled trials involving 1,051 patients with chronic neuropathic pain. The findings showed statistically significant improvements in both sleep quality and pain intensity, alongside clinically important patient-reported improvements. The study also highlights important limitations, formulation variability, and safety considerations clinicians should discuss with patients considering cannabinoid therapy.

Read More

What Pediatric Autism Cannabinoid Studies Actually Show

Cannabinoids for autism behavior are increasingly discussed by families seeking help for irritability, aggression, sleep, anxiety, and daily functioning. This review finds a limited but clinically relevant signal for selected outcomes, especially with high-CBD, low-THC formulations, while many standardized results remain mixed or null. The safest interpretation is careful, physician-guided, symptom-specific, and honest about what the evidence does not prove.

Read More

Cannabinoid Effects of Metamizol/Dipyrone: A Possible Second Life in Pediatric Anesthesia for a Vintage Drug.

Recent research demonstrates that metamizol/dipyrone exhibits cannabinoid effects in pediatric anesthesia applications, revealing endocannabinoid system interactions. This study provides mechanistic insights into how this vintage analgesic may achieve therapeutic effects through cannabinoid pathway modulation. Understanding metamizol cannabinoid effects could inform future pediatric pain management strategies.

Read More

Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1.

Recent research demonstrates that cannabidiphorol (CBDP) acts as a negative allosteric modulator at CB1 receptors through a novel dual-site mechanism. This finding suggests CBDP could potentially provide therapeutic cannabinoid system modulation without psychoactive effects, though clinical applications remain theoretical. The study represents important mechanistic research that expands our understanding of cannabinoid receptor pharmacology.

Read More

Therapeutic potential of acidic cannabinoids: an update.

A comprehensive review of acidic cannabinoids therapeutic potential reveals that THCA, CBDA, and related compounds offer unique neuroprotective and anti-inflammatory benefits distinct from THC and CBD. This systematic analysis challenges the traditional view of acidic forms as merely inactive precursors, establishing a foundation for expanded therapeutic applications.

Read More

Jolly Green Giant

The endocannabinoid system called, and it wants its cannabinoid ligand back. Giant stature optional, but improved appetite scientifically guaranteed. Via r/trees Further Reading Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1...

Read More